Kaustav Biswas
Senior Principal Scientist, Boston Discovery Chemistry Merck & Co
Seminars
Wednesday 29th April 2026
Peptide Industry Leaders’ Discussion – Unlocking Next Frontiers of Bioavailable Peptide-Based Therapeutics to Patients Faster
9:15 am
This your chance to hear from pioneering executive leaders the peptide space who will discuss their ambitions, strategies and challenges for peptide discovery, targets. indications and development of next generation of peptide drugs.
Key questions to be addressed include:
- What are the future opportunities, promising targets and applications on the horizon for peptide-drugs to achieve the next best in-market approval?
- Where is the next big wave heading after GLP-1 peptides?
- How will peptide-drugs compete against the biologics, antibody and small molecule markets as standards of care?
Wednesday 29th April 2026
Oral Macrocyclic Peptide Inhibitors of Cytokine Signaling
11:30 am
- Macrocyclic peptides derived from display-based technologies occupy the intermediate chemical space between small molecules and antibodies
- Chemical matter optimization strategies using structure-guided designs and non-canonical amino acids deliver drug-like leads
- Antibody-like biological activity can be achieved in blocking cytokine signaling implicated in immune-mediated diseases
